Total Funding
18
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
864149
NeuroVasx is engaged in the development of technologies for the minimally-invasive treatment of hemorrhagic and ischemic strokes.
- Steve Ferry: President and CEO
About the Company
NeuroVasx is a medical device company engaged in the development and commercialization of technologies for the minimally-invasive treatment of hemorrhagic and ischemic strokes in the United States and internationally.
The company offers cPAX, a polymer strand delivered through a micro catheter for the minimally-invasive treatment of hemorrhagic
and ischemic strokes as well as for the embolization of cerebral and intracranial aneurysms, abnormal bulges, and sacs in the wall of an artery in the brain. Its products are used to treat acute stroke and other cerebrovascular disorders.
NeuroVasx was founded in 1997 and is based in Maple Grove, Minnesota, United States.
